Stockreport

Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships [Yahoo! Finance]

Bluejay Diagnostics, Inc.  (BJDX) 
PDF Patient enrollment in SYMON-II clinical trial now approximately 50% completed. Recent private placement transaction completed in October 2025; Company continues to ex [Read more]